Leeward Investments LLC MA lessened its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 4.0% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 385,673 shares of the company's stock after selling 15,956 shares during the quarter. Leeward Investments LLC MA owned about 0.23% of Option Care Health worth $13,479,000 as of its most recent SEC filing.
A number of other hedge funds have also recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. grew its position in shares of Option Care Health by 6.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock valued at $58,235,000 after purchasing an additional 147,054 shares during the period. Keybank National Association OH raised its position in shares of Option Care Health by 15.4% during the 4th quarter. Keybank National Association OH now owns 18,613 shares of the company's stock worth $432,000 after purchasing an additional 2,489 shares during the period. Victory Capital Management Inc. grew its holdings in Option Care Health by 31.1% in the 4th quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company's stock worth $49,310,000 after buying an additional 503,840 shares in the last quarter. Assetmark Inc. boosted its stake in Option Care Health by 2.0% during the 4th quarter. Assetmark Inc. now owns 24,976 shares of the company's stock valued at $579,000 after purchasing an additional 487 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in shares of Option Care Health during the 4th quarter worth $2,027,000. Hedge funds and other institutional investors own 98.05% of the company's stock.
Analysts Set New Price Targets
Several equities analysts recently issued reports on the company. Barrington Research restated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research note on Wednesday, April 30th. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their price target for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research note on Wednesday, June 18th. One research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat, Option Care Health currently has an average rating of "Moderate Buy" and an average price target of $35.50.
Check Out Our Latest Stock Report on Option Care Health
Option Care Health Price Performance
OPCH stock traded down $0.96 during trading on Friday, hitting $30.07. 668,228 shares of the company's stock traded hands, compared to its average volume of 1,866,635. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The stock has a market capitalization of $4.92 billion, a price-to-earnings ratio of 24.25, a P/E/G ratio of 1.88 and a beta of 0.73. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.02 and a current ratio of 1.54. The business has a fifty day simple moving average of $31.97 and a 200 day simple moving average of $31.09.
Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. The business had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a net margin of 4.12% and a return on equity of 16.90%. The company's revenue was up 16.3% compared to the same quarter last year. During the same period last year, the business earned $0.26 EPS. As a group, research analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.